New Delhi [India], June 4: VedicDerm, an emerging Ayurvedic dermatology brand, has launched a steroid-free topical cream for psoriasis, offering new hope to millions suffering from this chronic skin condition. What makes this product different is not just its Ayurvedic foundation, but its scientific validation.

In independent lab tests conducted in April 2025, VedicDerm’s Psoriasis Cream demonstrated a remarkable reduction in key inflammatory biomarkers:

  • Histamine levels reduced by 91.82%
  • Substance P was reduced by up to 99.12%
  • Interleukin-17 (IL-17) reduced by up to 74%
  • Interleukin-23 (IL-23) reduced by up to 90%

These biomarkers are directly associated with itching, redness, plaque formation, and immune dysregulation in psoriasis patients. The tests were conducted using 3D-cultured HaCaT cell lines under in vitro conditions.

“Steroid creams can offer temporary relief, but often cause rebound flare-ups and skin thinning,” says Dr. Samyak Dhawan, Founder of VedicDerm and Medical Director at Kayakalp Global. “We set out to create a long-term, barrier-safe alternative that supports the skin’s immune balance.”

Formulated with six clinically studied herbs such as Manjishtha, Mulethi, Aloe Vera, Neem Oil, Tea Tree Oil, and Babchi, the cream uses a proprietary base designed for deep penetration without synthetic steroids, parabens, or petrochemicals.

Psoriasis affects nearly 3% of India’s population, with many patients facing stigma, long-term side effects from steroid misuse, and limited access to affordable, practical solutions.

VedicDerm’s cream fills that gap already being used in its national telemedicine psoriasis program, with hundreds of success stories emerging from Tier 2 and Tier 3 cities.

Now available on www.vedicderm.com and across major marketplaces, this launch is not just another Ayurvedic product; it’s a scientifically backed solution that bridges traditional wisdom and modern efficacy.

About VedicDermVedicDerm is a doctor-led Ayurvedic skincare brand built on deep clinical insights and modern R&D. Its formulations target chronic conditions like psoriasis, eczema, pigmentation, and hair loss, using a first-in-India combination of plant stem cells, nanoactives, and biomarker-based validation.

Disclaimer: This is a featured article. ABP Network Pvt. Ltd. and/or ABP Live do not endorse/subscribe to its contents and/or views expressed herein. All information is provided on an as-is basis. The information does not constitute advice or an offer to buy. Consult an expert advisor/health professional before any such purchase. Reader discretion is advised.